Cargando…
Peptide-Based Vaccines and Therapeutics for COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been prevalent in the humans since 2019 and has given rise to a pandemic situation. With the discovery and ongoing use of drugs and vaccines against SARS-CoV-2, there is still no surety of its complete suppression of this disease or if...
Autores principales: | Bagwe, Pritam V., Bagwe, Priyal V., Ponugoti, Sai Srinivas, Joshi, Shreerang V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017722/ https://www.ncbi.nlm.nih.gov/pubmed/35463185 http://dx.doi.org/10.1007/s10989-022-10397-y |
Ejemplares similares
-
An Overview of Current Accomplishments and Gaps of COVID-19 Vaccine Platforms and Considerations for Next Generation Vaccines
por: Kale, Akanksha, et al.
Publicado: (2023) -
Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated Neisseria gonorrhoeae Microparticle Vaccine Formulation
por: Bagwe, Priyal, et al.
Publicado: (2022) -
Meningococcal Vaccines: Challenges and Prospects
por: Bagwe, Priyal, et al.
Publicado: (2020) -
Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-like Particle (M2e VLP) Using Polymeric Microparticles for Vaccine Delivery
por: Gomes, Keegan Braz, et al.
Publicado: (2022) -
Microneedle Delivery of an Adjuvanted Microparticulate Vaccine Induces High Antibody Levels in Mice Vaccinated against Coronavirus
por: Vijayanand, Sharon, et al.
Publicado: (2022)